Literature DB >> 15642853

Parkin mutations and early-onset parkinsonism in a Taiwanese cohort.

Ruey-Meei Wu1, Rebecca Bounds, Sarah Lincoln, Mary Hulihan, Chin-Hsien Lin, Wuh-Liang Hwu, Judy Chen, Katrina Gwinn-Hardy, Matt Farrer.   

Abstract

BACKGROUND: Loss of function of the parkin gene (PRKN) is the predominant genetic cause of juvenile and early-onset parkinsonism in Japan, Europe, and the United States.
OBJECTIVES: To evaluate the frequency of PRKN mutations in Taiwanese (ethnic Chinese) patients with early-onset parkinsonism and to explore genotype-phenotype correlations.
DESIGN: Clinical assessment included medical, neurologic, and psychiatric evaluation. Genomic DNA sequencing and quantitative polymerase chain reaction were performed to identify PRKN mutations. Gene expression was examined in patient lymphoblastoid cell lines, in which PRKN mutations were identified. PATIENTS: Forty-one Taiwanese patients with early-onset parkinsonism (aged <50 years at onset).
RESULTS: Four of 41 probands had PRKN mutations. One proband had compound heterozygous mutations, with a PRKN exon 2 deletion and an exon 7 G284R substitution. The phenotype resembled typical Parkinson disease. Three patients were mutation carriers. One proband had PRKN exon 2 and exon 3 deletions in the same allele. However, this patient's phenotype was that of classic "parkin-proven" autosomal recessive juvenile parkinsonism, characterized by symmetrical foot dystonia at onset, gait disturbance, diurnal change, and very slow progression. The 2 remaining carriers had novel heterozygous exon 11 R396G substitutions. Patients with PRKN mutations were younger at onset than those without mutations, and they required a lower dose of levodopa despite longer disease duration.
CONCLUSIONS: Mutations in PRKN are a rare cause of early-onset parkinsonism in Taiwanese individuals. The overall mutation frequency, adjusted for age at onset, was comparable with that reported for white cohorts; however, the point mutations identified seem to be population specific.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15642853     DOI: 10.1001/archneur.62.1.82

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  20 in total

1.  Parkinson's disease in China.

Authors:  You-yong Tian; Cui-ju Tang; Jie Wu; Jun-shan Zhou
Journal:  Neurol Sci       Date:  2010-12-14       Impact factor: 3.307

2.  Phenotype analysis in patients with early onset Parkinson's disease with and without parkin mutations.

Authors:  Hee Jin Kim; Han-Joon Kim; Jee-Young Lee; Ji Young Yun; So Yeon Kim; Sung Sup Park; Beom S Jeon
Journal:  J Neurol       Date:  2011-05-29       Impact factor: 4.849

3.  Mutation analysis of Parkin, PINK1 and DJ-1 genes in Chinese patients with sporadic early onset parkinsonism.

Authors:  Ji-feng Guo; Xue-wei Zhang; Li-luo Nie; Hai-nan Zhang; Bin Liao; Jing Li; Lei Wang; Xin-xiang Yan; Bei-sha Tang
Journal:  J Neurol       Date:  2010-02-10       Impact factor: 4.849

Review 4.  Twenty years since the discovery of the parkin gene.

Authors:  Nobutaka Hattori; Yoshikuni Mizuno
Journal:  J Neural Transm (Vienna)       Date:  2017-06-15       Impact factor: 3.575

5.  Novel variant Pro143Ala in HTRA2 contributes to Parkinson's disease by inducing hyperphosphorylation of HTRA2 protein in mitochondria.

Authors:  Chin-Hsien Lin; Meng-Ling Chen; Grace Shiahuy Chen; Chun-Hwei Tai; Ruey-Meei Wu
Journal:  Hum Genet       Date:  2011-06-24       Impact factor: 4.132

6.  Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease.

Authors:  L N Clark; B M Ross; Y Wang; H Mejia-Santana; J Harris; E D Louis; L J Cote; H Andrews; S Fahn; C Waters; B Ford; S Frucht; R Ottman; K Marder
Journal:  Neurology       Date:  2007-09-18       Impact factor: 9.910

7.  Identification and characterization of a novel endogenous murine parkin mutation.

Authors:  Chenere P Ramsey; Benoit I Giasson
Journal:  J Neurochem       Date:  2010-01-20       Impact factor: 5.372

8.  PARK2 mutations and clinical features in a Chinese population with early-onset Parkinson's disease.

Authors:  Daniel Kam Yin Chan; Vincent Mok; Ping Wing Ng; Jonas Yeung; John B Kwok; Zhi Ming Fang; Raymond Clarke; Lawrence Wong; Peter R Schofield; Nobutaka Hattori
Journal:  J Neural Transm (Vienna)       Date:  2008-01-11       Impact factor: 3.575

Review 9.  Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update.

Authors:  Karen Nuytemans; Jessie Theuns; Marc Cruts; Christine Van Broeckhoven
Journal:  Hum Mutat       Date:  2010-07       Impact factor: 4.878

10.  Structure and function of Parkin E3 ubiquitin ligase reveals aspects of RING and HECT ligases.

Authors:  B E Riley; J C Lougheed; K Callaway; M Velasquez; E Brecht; L Nguyen; T Shaler; D Walker; Y Yang; K Regnstrom; L Diep; Z Zhang; S Chiou; M Bova; D R Artis; N Yao; J Baker; T Yednock; J A Johnston
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.